Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Change in Receivables (2020 - 2025)

Healthcare Triangle filings provide 6 years of Change in Receivables readings, the most recent being -$334000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 51.52% to -$334000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $913000.0, a 139.44% increase, with the full-year FY2025 number at $913000.0, up 139.44% from a year prior.
  • Change in Receivables reached -$334000.0 in Q4 2025 per HCTI's latest filing, down from $495000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $3.8 million in Q4 2021, with the low at -$2.9 million in Q1 2022.
  • A 5-year average of -$199050.0 and a median of -$236000.0 in 2022 define the central range for Change in Receivables.
  • Year-over-year, Change in Receivables tumbled 36562.5% in 2022 and then skyrocketed 225.32% in 2025.
  • Year by year, Change in Receivables stood at $3.8 million in 2021, then plummeted by 116.34% to -$615000.0 in 2022, then plummeted by 42.11% to -$874000.0 in 2023, then increased by 21.17% to -$689000.0 in 2024, then surged by 51.52% to -$334000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Change in Receivables are -$334000.0 (Q4 2025), $495000.0 (Q3 2025), and -$45000.0 (Q2 2025).